- “As these cryopreserved biological materials belong to patients and represent critical human tissue for family building, the ongoing monitoring and management of cryopreservation tanks is imperative,” the company says
- IntegraMed is seeking protection from its creditors as it winds down operations and transfers fertility treatments to third-party facilities
- Lists up to $500 million in assets and liabilities
- IntegraMed manages in-vitro fertilization clinics ...
May 22, 2020, 4:12 PM